RTW Biotech Opportunities Ltd
						RTWFF
					
					
							
								$1.66
								-$0.09-5.14%
								
							
						OTC PK
					
				| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | 
| Total Other Revenue | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M | 
| Total Revenue | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M | 
| Cost of Revenue | -- | -- | -- | -- | -- | 
| Gross Profit | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M | 
| SG&A Expenses | 3.08M | 3.08M | 3.07M | 3.07M | 2.58M | 
| Depreciation & Amortization | -- | -- | -- | -- | -- | 
| Other Operating Expenses | -- | -- | -- | -- | -- | 
| Total Operating Expenses | 3.41M | 3.41M | 3.33M | 3.33M | 2.75M | 
| Operating Income | 11.48M | 11.48M | -668.80K | -668.80K | -1.32M | 
| Income Before Tax | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M | 
| Income Tax Expenses | -- | -- | -- | -- | -- | 
| Earnings from Continuing Operations | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M | 
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- | 
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- | 
| Minority Interest in Earnings | -- | -- | -- | -- | -- | 
| Net Income | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M | 
| EBIT | 11.48M | 11.48M | -668.80K | -668.80K | -1.32M | 
| EBITDA | -- | -- | -- | -- | -- | 
| EPS Basic | -0.06 | -0.06 | -0.08 | -0.08 | 0.13 | 
| Normalized Basic EPS | 0.01 | 0.01 | -0.02 | -0.02 | 0.06 | 
| EPS Diluted | -0.06 | -0.06 | -0.08 | -0.08 | 0.13 | 
| Normalized Diluted EPS | 0.01 | 0.01 | -0.02 | -0.02 | 0.06 | 
| Average Basic Shares Outstanding | 330.06M | 330.06M | 335.71M | 335.71M | 335.71M | 
| Average Diluted Shares Outstanding | 330.06M | 330.06M | 335.71M | 335.71M | 335.71M | 
| Dividend Per Share | -- | -- | -- | -- | -- | 
| Payout Ratio | -- | -- | -- | -- | -- |